These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15867644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1440-50. PubMed ID: 15590175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C, Han F, Lu LX, Huang SM, Lin CG, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [Abstract] [Full Text] [Related]

  • 7. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH, Woo SY, Cui NJ, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):682-7. PubMed ID: 14967420
    [Abstract] [Full Text] [Related]

  • 8. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A, Lin K, Tiong CE, Tan LK, Loh TK, Goh BC, Lu JJ.
    Laryngoscope; 2006 Jun 01; 116(6):938-43. PubMed ID: 16735885
    [Abstract] [Full Text] [Related]

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 10. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):363-73. PubMed ID: 15925451
    [Abstract] [Full Text] [Related]

  • 11. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
    Xie CY, Wu SX, Jin XC, Yu JY, Wang JH, Li WF, Zhang P.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2412-5. PubMed ID: 18036320
    [Abstract] [Full Text] [Related]

  • 12. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
    Lee SW, Back GM, Yi BY, Choi EK, Ahn SD, Shin SS, Kim JH, Kim SY, Lee BJ, Nam SY, Choi SH, Kim SB, Park JH, Lee KK, Park SH, Kim JH.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):152-60. PubMed ID: 16472934
    [Abstract] [Full Text] [Related]

  • 13. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
    Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1071-8. PubMed ID: 19362784
    [Abstract] [Full Text] [Related]

  • 14. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK, Clery M, Ang KK, Byhardt RW, Maor MH, Beitler JJ.
    Int J Radiat Oncol Biol Phys; 1995 Jun 15; 32(3):589-97. PubMed ID: 7790243
    [Abstract] [Full Text] [Related]

  • 15. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA, Morra A, DeBraud F, Alterio D, Mazzetta C, Rocca A, Catalano G, Bianchi L, Pasetti M, Chiesa F, Bruschini R, Orecchia R.
    Strahlenther Onkol; 2004 Jul 15; 180(7):425-33. PubMed ID: 15241530
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH, Kal HB, Hordijk GJ.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):62-9. PubMed ID: 15850903
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
    Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He S.
    Laryngoscope; 2008 Jul 01; 118(7):1206-10. PubMed ID: 18418278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.